Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Enterococcus species, particularly Enterococcus faecium, have been investigated as probiotics for gastrointestinal health, including the management of Irritable Bowel Syndrome (IBS). The rationale for their use is based on their role in modulating gut microbiota, enhancing intestinal barrier function, and modulating immune responses. Several small clinical trials and some observational studies have evaluated the efficacy of Enterococcus-containing probiotic formulations (often in combination with other bacterial strains) in alleviating IBS symptoms such as bloating, abdominal pain, and irregular bowel movements.

While some studies have reported modest improvements in certain IBS symptoms, the quality of evidence remains limited. Most trials have small sample sizes, short durations, and often use multi-strain probiotic mixtures, making it difficult to isolate the effect of Enterococcus species specifically. Systematic reviews and meta-analyses of probiotics for IBS generally include Enterococcus-based products among many other strains, and typically conclude that while probiotics may offer benefits to some patients, the evidence for any single strain—including Enterococcus—is not strong or consistent.

Safety concerns have also been raised regarding the use of Enterococcus, as some strains can act as opportunistic pathogens and may carry antibiotic resistance genes. As such, their use as a probiotic is more common in some countries (e.g., certain products in Europe and Asia) than others. In summary, there is some scientific investigation into Enterococcus for IBS, but the evidence is limited and does not robustly support its widespread use.

More about Enterococcus (various species)
More about Irritable Bowel Syndrome

Other ingredients used for Irritable Bowel Syndrome

Other health conditions supported by Enterococcus (various species)

Products containing Enterococcus (various species)